OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple roles for orexin/hypocretin in addiction
Stephen V. Mahler, Rachel J. Smith, David E. Moorman, et al.
Progress in brain research (2012), pp. 79-121
Open Access | Times Cited: 211

Showing 26-50 of 211 citing articles:

Medications for alcohol use disorders: An overview
Mohammed Akbar, Mark Egli, Young‐Eun Cho, et al.
Pharmacology & Therapeutics (2017) Vol. 185, pp. 64-85
Open Access | Times Cited: 86

Strategies to reduce aspecific adsorption of peptides and proteins in liquid chromatography–mass spectrometry based bioanalyses: An overview
Katrien Maes, Ilse Smolders, Yvette Michotte, et al.
Journal of Chromatography A (2014) Vol. 1358, pp. 1-13
Closed Access | Times Cited: 85

Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats
Brooke E. Schmeichel, Melissa A. Herman, Marisa Roberto, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 7, pp. 606-615
Open Access | Times Cited: 85

Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention
Mathieu Nollet, Samuel Leman
CNS Drugs (2013) Vol. 27, Iss. 6, pp. 411-422
Closed Access | Times Cited: 80

The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79

The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation
Michela Ferrucci, Fiona Limanaqi, Larisa Ryskalin, et al.
Frontiers in Neuroanatomy (2019) Vol. 13
Open Access | Times Cited: 74

Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73

Hypocretin Receptor 2 Antagonism Dose-Dependently Reduces Escalated Heroin Self-Administration in Rats
Brooke E. Schmeichel, Estelle Barbier, Kaushik Misra, et al.
Neuropsychopharmacology (2014) Vol. 40, Iss. 5, pp. 1123-1129
Open Access | Times Cited: 71

Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine
Taylor A. Gentile, Steven J. Simmons, David J. Barker, et al.
Addiction Biology (2017) Vol. 23, Iss. 1, pp. 247-255
Open Access | Times Cited: 70

Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner
David E. Moorman, Morgan H. James, Elisabeth A. Kilroy, et al.
European Journal of Neuroscience (2016) Vol. 43, Iss. 5, pp. 710-720
Open Access | Times Cited: 67

The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice
Marcelo F. Lopez, David E. Moorman, Gary Aston‐Jones, et al.
Brain Research (2016) Vol. 1636, pp. 74-80
Open Access | Times Cited: 66

Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats
Robyn M. Brown, Andrezza K. Kim, Shaun Yon‐Seng Khoo, et al.
Addiction Biology (2015) Vol. 21, Iss. 3, pp. 603-612
Open Access | Times Cited: 64

Cyclic tailor-made amino acids in the design of modern pharmaceuticals
Jiang Liu, Jianlin Han, Kunisuke Izawa, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112736-112736
Closed Access | Times Cited: 57

Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50

Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder
George F. Koob, Leandro F. Vendruscolo
Current topics in behavioral neurosciences (2023)
Closed Access | Times Cited: 17

A Role for Hypocretin/Orexin Receptor-1 in Cue-Induced Reinstatement of Nicotine-Seeking Behavior
Ainhoa Plaza‐Zabala, África Flores, Elena Martín‐García, et al.
Neuropsychopharmacology (2013) Vol. 38, Iss. 9, pp. 1724-1736
Open Access | Times Cited: 66

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
África Flores, Rafaël Maldonado, Fernando Berrendero
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 63

The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review
Rama Kamal, Martijn S. van Noorden, Ernst Franzek, et al.
Neuropsychobiology (2016) Vol. 73, Iss. 2, pp. 65-80
Open Access | Times Cited: 59

Binge‐Like Consumption of Ethanol and Other Salient Reinforcers is Blocked by Orexin‐1 Receptor Inhibition and Leads to a Reduction of Hypothalamic Orexin Immunoreactivity
Jeffrey J. Olney, Montserrat Navarro, Todd E. Thiele
Alcoholism Clinical and Experimental Research (2015) Vol. 39, Iss. 1, pp. 21-29
Open Access | Times Cited: 58

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
Emilio Merlo Pich, Sergio Melotto
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 57

Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food
Rémi Martin‐Fardon, Gabrielle Cauvi, Tony M. Kerr, et al.
Addiction Biology (2016) Vol. 23, Iss. 1, pp. 6-15
Open Access | Times Cited: 55

A food-predictive cue attributed with incentive salience engages subcortical afferents and efferents of the paraventricular nucleus of the thalamus
Joshua L. Haight, Zachary L. Fuller, Kurt M. Fraser, et al.
Neuroscience (2016) Vol. 340, pp. 135-152
Open Access | Times Cited: 55

Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55

Lesions of the paraventricular nucleus of the thalamus differentially affect sign‐ and goal‐tracking conditioned responses
Joshua L. Haight, Kurt M. Fraser, Huda Akil, et al.
European Journal of Neuroscience (2015) Vol. 42, Iss. 7, pp. 2478-2488
Open Access | Times Cited: 54

Scroll to top